The Journal of Urology
Volume 179, Issue 2 , Pages 764-769, February 2008

Abnormal Expression of Differentiation Related Proteins and Proteoglycan Core Proteins in the Urothelium of Patients With Interstitial Cystitis

  • Paul J. Hauser

      Affiliations

    • Department of Urology, College of Medicine, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma
  • ,
  • Mikhail G. Dozmorov

      Affiliations

    • Department of Urology, College of Medicine, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma
  • ,
  • Barbara L. Bane

      Affiliations

    • Department of Pathology, College of Medicine, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma
  • ,
  • Gennady Slobodov

      Affiliations

    • Department of Urology, College of Medicine, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma
  • ,
  • Daniel J. Culkin

      Affiliations

    • Department of Urology, College of Medicine, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma
  • ,
  • Robert E. Hurst

      Affiliations

    • Department of Urology, College of Medicine, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma
    • Department of Biochemistry and Molecular Biology, College of Medicine, Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma
    • Corresponding Author InformationCorrespondence: Department of Urology, Oklahoma University Health Sciences Center, 940 S. L. Young Blvd., Oklahoma City, Oklahoma 73104 (telephone; 405-271-3930; FAX: 405-271-3289).
    • Financial interest and/or other relationship with Stellar Pharmaceuticals.

Received 1 May 2007 published online 14 December 2007.

Purpose

Expression of the proteoglycan core proteins biglycan, decorin, perlecan and syndecan-1, and differentiation related markers of keratins 18 and 20 were examined to determine the origins of the loss of the glycosaminoglycan layer and investigate more fully the altered differentiation of the urothelium in interstitial cystitis.

Materials and Methods

Formalin fixed biopsies from 27 patients with interstitial cystitis and 5 controls were immunohistochemically labeled for the described proteins and scored using a modification of previous scoring for other markers. Inflammation was scored from hematoxylin and eosin stained slides. By combining previous with new data, cluster analysis showed the relationships among the markers and samples.

Results

Interstitial cystitis specimens clustered into 4 groups, ranging from most biomarkers abnormal to most biomarkers normal, but all clustered separately from normal controls. One group of interstitial cystitis specimens mainly showed aberrant expression of E-cadherin, which might represent an early abnormality. The biomarkers fell into 2 major groupings. One group consisted of chondroitin sulfate, perlecan, biglycan, decorin and the tight junction protein ZO-1. A second cluster consisted of uroplakin, the epithelial marker keratin 18 and 20, and the morphology of the layer. E-cadherin and syndecan-1 showed little relation to the other 2 clusters or to each other. Inflammation correlated moderately with syndecan-1 but to no other marker.

Conclusions

Findings strongly suggest abnormal differentiation in the interstitial cystitis urothelium with a loss of barrier function markers and altered differentiation markers being independent and occurring independently of inflammation. Loss of the glycosaminoglycan layer was associated with a loss of biglycan and perlecan on the luminal layer.

Key Words: bladder, cystitis, interstitial, urothelium, glycosaminoglycans, cell differentiation

Abbreviations and Acronyms: FGF, fibroblastic growth factor, GAG, glycosaminoglycan, IC, interstitial cystitis, IHC, immunohistochemistry, TGF-β, transforming growth factor-β

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by R01 DK069808 (REH), a grant from Stellar Pharmaceuticals, Ltd. (REH) and the Department of Urology.

PII: S0022-5347(07)02493-7

doi:10.1016/j.juro.2007.09.022

The Journal of Urology
Volume 179, Issue 2 , Pages 764-769, February 2008